BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Javed AA, Wright MJ, Siddique A, Blair AB, Ding D, Burkhart RA, Makary M, Cameron JL, Narang A, Herman J, Zheng L, Laheru D, Weiss MJ, Wolfgang C, He J. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy. J Gastrointest Surg 2019;23:112-21. [PMID: 30242644 DOI: 10.1007/s11605-018-3966-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Ishido K, Hakamada K, Kimura N, Miura T, Wakiya T. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma. Ann Gastroenterol Surg 2021;5:7-23. [PMID: 33532676 DOI: 10.1002/ags3.12379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Song KB, Kwon J, Kim YW, Hwang DW, Lee JH, Hong S, Lee JW, Hwang K, Yoo D, Kim SC. Prognostic value of adjacent organ resection in patients with left‐sided pancreatic ductal adenocarcinoma following distal pancreatectomy. J Hepatobiliary Pancreat Sci 2019;26:227-34. [DOI: 10.1002/jhbp.627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Bhogal RH, Pericleous S, Khan AZ. Open and Minimal Approaches to Pancreatic Adenocarcinoma. Gastroenterol Res Pract 2020;2020:4162657. [PMID: 32565781 DOI: 10.1155/2020/4162657] [Reference Citation Analysis]
4 Sugimachi K, Iguchi T, Mano Y, Morita M, Mori M, Toh Y. Significance of bile culture surveillance for postoperative management of pancreatoduodenectomy. World J Surg Oncol 2019;17:232. [PMID: 31888657 DOI: 10.1186/s12957-019-1773-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Blair AB, Yin LD, Pu N, Yu J, Groot VP, Rozich NS, Javed AA, Zheng L, Cameron JL, Burkhart RA, Weiss MJ, Wolfgang CL, He J. Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer. Ann Surg 2021;274:162-9. [PMID: 32304375 DOI: 10.1097/SLA.0000000000003570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
6 Ahmed SA, Mourad AF, Hassan RA, Ibrahim MAE, Soliman A, Aboeleuon E, Elbadee OMA, Hetta HF, Jabir MA. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: accuracy in the prediction of vascular invasion and resectability. Abdom Radiol 2021;46:280-9. [DOI: 10.1007/s00261-020-02605-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nurmi AM, Mustonen HK, Stenman UH, Seppänen HE, Haglund CH. Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma. Sci Rep 2021;11:781. [PMID: 33437015 DOI: 10.1038/s41598-020-80778-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Groot VP, Blair AB, Gemenetzis G, Ding D, Burkhart RA, Yu J, Borel Rinkes IH, Molenaar IQ, Cameron JL, Weiss MJ, Wolfgang CL, He J. Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer. European Journal of Surgical Oncology 2019;45:1674-83. [DOI: 10.1016/j.ejso.2019.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
9 Chaudhari VA, Mitra A, Gupta V, Ostwal V, Ramaswamy A, Engineer R, Sirohi B, Shetty N, Bal M, Desouza A, Bhandare MS, Shrikhande SV. Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving evidence. Surgery 2021. [DOI: 10.1016/j.surg.2021.10.018] [Reference Citation Analysis]
10 Rom H, Tamir S, Van Vugt JLA, Berger Y, Perl G, Morgenstern S, Tovar A, Brenner B, Benchimol D, Kashtan H, Sadot E. Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy. Ann Surg Oncol 2021. [PMID: 34716836 DOI: 10.1245/s10434-021-10995-y] [Reference Citation Analysis]
11 Kasahara N, Noda H, Kakizawa N, Kato T, Watanabe F, Ichida K, Endo Y, Aizawa H, Rikiyama T. A lack of postoperative complications after pancreatectomy contributes to the long-term survival of patients with pancreatic cancer. Pancreatology 2019;19:686-94. [PMID: 31253497 DOI: 10.1016/j.pan.2019.06.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Okabe H, Yamashita Y, Inoue R, Kinoshita S, Itoyama R, Yusa T, Nakao Y, Yamao T, Umezaki N, Tsukamoto M, Kitano Y, Miyata T, Arima K, Hayashi H, Imai K, Chikamoto A, Baba H. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. Surg Today 2020;50:193-9. [DOI: 10.1007/s00595-019-01866-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Blair AB, Groot VP, He J. Lessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironment. Ann Transl Med 2019;7:S9. [PMID: 31032290 DOI: 10.21037/atm.2019.01.32] [Reference Citation Analysis]
14 Kato H, Horiguchi A, Ito M, Asano Y, Arakawa S. Essential updates 2019/2020: Multimodal treatment of localized pancreatic adenocarcinoma: Current topics and updates in survival outcomes and prognostic factors. Ann Gastroenterol Surg 2021;5:132-51. [PMID: 33860134 DOI: 10.1002/ags3.12427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Holyoake DLP, Robinson M, Silva M, Grose D, McIntosh D, Sebag-Montefiore D, Radhakrishna G, Mukherjee S, Hawkins MA. SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer. Radiother Oncol 2021;155:278-84. [PMID: 33217498 DOI: 10.1016/j.radonc.2020.11.007] [Reference Citation Analysis]
16 Artioli G, Besutti G, Cassetti T, Sereni G, Zizzo M, Bonacini S, Carlinfante G, Panebianco M, Cavazza A, Pinto C, Sassatelli R, Pattacini P, Giorgi Rossi P. Impact of multidisciplinary approach and radiologic review on surgical outcome and overall survival of patients with pancreatic cancer: a retrospective cohort study. Tumori 2021;:300891621999092. [PMID: 33719770 DOI: 10.1177/0300891621999092] [Reference Citation Analysis]
17 Maggino L, Malleo G, Marchegiani G, Viviani E, Nessi C, Ciprani D, Esposito A, Landoni L, Casetti L, Tuveri M, Paiella S, Casciani F, Sereni E, Binco A, Bonamini D, Secchettin E, Auriemma A, Merz V, Simionato F, Zecchetto C, D'Onofrio M, Melisi D, Bassi C, Salvia R. Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma. JAMA Surg 2019;154:932-42. [PMID: 31339530 DOI: 10.1001/jamasurg.2019.2277] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
18 Jia AY, Popovic A, Mohan AA, Zorzi J, Griffith P, Kim AK, Anders RA, Burkhart RA, Lafaro K, Georgiades C, Azad NS, Liddell RP, Baretti M, Kamel IR, Narang A, Yarchoan M, Meyer J. Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic. Cancer Control 2021;28:10732748211009945. [PMID: 33882707 DOI: 10.1177/10732748211009945] [Reference Citation Analysis]
19 Lapshyn H, Schulte T, Sondermann S, May K, Petrova E, Honselmann KC, Braun R, Zemskov S, Keck T, Wellner UF, Bausch D, Bolm L. Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. Pancreatology 2021;21:155-62. [PMID: 33309623 DOI: 10.1016/j.pan.2020.11.015] [Reference Citation Analysis]
20 Ahmed SA, Atta H, Hassan RA. The utility of Multi-Detector Computed Tomography criteria after neoadjuvant therapy in Borderline Resectable Pancreatic cancer: Prospective, bi-institutional study. Eur J Radiol 2021;139:109685. [PMID: 33819805 DOI: 10.1016/j.ejrad.2021.109685] [Reference Citation Analysis]